At Somahlution, we work with medical professionals and hospitals to provide new medical technologies that not only benefit patients globally, but also help hospitals improve their quality performance ratings. In an ever increasing competitive healthcare environment in which there is a growing movement to tie reimbursement to quality performance and outcomes, medical professionals and hospitals strive to set themselves apart. Somahlution’s products can help to create that competitive advantage.
Somahlution’s flagship product is called DuraGraft®. DuraGraft is a vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure. DuraGraft enhances CABG outcomes by significantly reducing major cardiac events such as repeat revascularization, myocardial infarction and MACE. Reduced complications lead to lower readmissions, significantly reducing hospital costs and improving hospital performance ratings.
The implementation and use of DuraGraft is simple and does not modify current practice, thus allowing surgeons and hospitals to improve their quality of care simply and seamlessly. Somahlution understands the unique needs of medical professionals and hospitals and is committed to ensuring that they provide high-quality care through the use of products like DuraGraft.